Home > Pressrelease > Atrial Fibrillation Devices Market worth over $12.5bn by 2025

Atrial Fibrillation Devices Market worth over $12.5bn by 2025

  • Published Date: April 18, 2019

Atrial Fibrillation Devices Market size is set to exceed USD 12.5 billion by 2025, according to a new research study published by Global Market Insights Inc.

Presence of sophisticated healthcare infrastructure and rising adoption rate of advanced technologies will be the major factors driving the market growth. Furthermore, increasing baby boomers across the globe and availability of reimbursement scenario in developed regions will prove to be high market impact rendering factor for propelling the market expansion.

Inadequate infrastructure in under-developed and developing regions to support atrial fibrillation procedures is a growth hindering factor. Also, high prices of such devices might hinder acceptance rates in various economies across the world. Price constraint will continue to impede the industry growth.

U.S. Atrial Fibrillation Devices Market, By Product

Get more details on this report - Request Free Sample PDF

Cardiac monitors or implantable loop recorder segment was valued around USD 807.1 million in 2018. Gradual increasing acceptance of cardiac monitors will augment the industry expansion in the coming years. The adoption rate of cardiac monitors is increasing owing to efficient long-term heart rhythm monitoring it offers as compared to other standard Holter monitor or electrocardiogram. Moreover, rising demand for minimally invasive procedures is a major factor fostering the growth of the market. The growing application of such devices is mainly associated with current technological enhancements including easier implant surgeries, miniaturization and remote nursing, all of it making this approach more promising and appealing.

Browse key industry insights spread across 500 pages with 805 market data tables & 30 figures & charts from the report,Atrial Fibrillation Devices Market Size By Product (EP Ablation Catheters {Radiofrequency, Laser, Cryoablation, Ultrasound, Microwave}, EP Diagnostic Catheters {Fixed Curve Catheters, Steerable Catheters, Advanced Mapping Catheters}, Mapping and Recording Systems, Cardiac Monitors or Implantable Loop Recorder, Access Devices, Intracardiac Echocardiography, Left Atrial Appendage Closure Devices), By End-use (Hospitals, Cardiac Centres, Ambulatory Surgical Centres) Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025in detail along with the table of contents:


The use of atrial fibrillation devices in hospitals is estimated to witness 14.2% growth rate through 2025. Rising popularity of multi-specialty hospitals in developing and developed countries will strongly contribute to greater demand for atrial fibrillation devices in this setting. Additionally, increasing preference of patients for hospital settings over other medical facilities will further fuel the market progression.

U.S. market is poised to expand at more than 13.9% CAGR during 2018 to 2025. Modern healthcare infrastructure, developing hospital sector, growing usage of novel devices to address severe conditions of patients suffering from atrial fibrillation and growing rate of geriatric population in the country should spur the U.S. market during the forecast years.

Some of the key companies operating in the global market are Abbott Laboratories, Johnson & Johnson, Atricure Inc., Microport Scientific Corporation, Boston Scientific Corporation, St. Jude medical, Inc., Medtronic Plc, Koninklijke Philips N.V., and Siemens AG. The industry participants emphasize on mergers and acquisitions, new product developments, and geographical expansion to strengthen their foothold in the market and gain competitive advantage over its peers.

Authors: Sumant Ugalmugle, Rupali Swain